Organometallics
Article
CD3CN) δ: 7.35−7.65 (m, 12H, ArH), 6.95 (dddd, J = 8.1, 7.1, 2.1,
1.1 Hz, 1H, ArH), 6.41 (ddd, J = 8.2, 5.8, 1.2 Hz, 1H, ArH), 2.37 (s,
12H, CH3). 13C{1H} NMR (126 MHz, CD3CN) δ: 181.2 (br, s, cis
CO), 178.2 (br, d, 2JCP = 39.1 Hz, trans CO), 163.6 (s, CN), 156.8
(d, JCP = 8.6 Hz, Ar), 134.4 (s, Ar), 134.3 (d, JCP = 10.7 Hz, Ar), 133.7
(d, JCP = 6.0 Hz, Ar), 132.7 (d, JCP = 2.5 Hz, Ar), 132.6 (d, JCP = 53.0
Hz, Ar), 130.1 (d, JCP = 10.7 Hz, Ar), 122.9 (d, JCP = 6.9 Hz, Ar),
119.8 (d, JCP = 9.8 Hz, Ar), 115.9 (d, JCP = 57.8 Hz, Ar), 39.7 (s, CH3).
CH2Cl2. To the yellow solution was added HBF4·Et2O (18 μL, 0.13
mmol, 1.1 equiv), which immediately resulted in the formation of a
white solid. The mixture was stirred for 10 min and then allowed to
settle. The supernatant was decanted, and the product washed with 2
mL of CH2Cl2 and 2 × 2 mL of Et2O before drying in vacuo. Yield:
101 mg (91.0%). 1H NMR (300 MHz, CD3CN) δ: 17.08 (br, s, NH),
8.24 (dd, J = 3.6, 1.3 Hz, 1H, ArH), 8.21 (dd, J = 2.9, 1.3 Hz, 1H,
ArH), 8.08 (dd, J = 7.8, 1.3 Hz, 1H, ArH), 7.87−8.02 (m, 2H, ArH),
7.59−7.74 (m, 10H, ArH), 3.29 (d, J = 4.2 Hz, 6H, CH3), 2.50 (d, J =
0.6 Hz, 6H, CH3). 13C{1H} NMR (126 MHz, CD3CN) δ: 180.2 (d,
2JCP = 8.2 Hz, cis CO), 176.2 (d, 2JCP = 42.8 Hz, trans CO), 149.3 (s,
Ar), 143.1 (s, Ar), 138.4 (s, Ar), 135.8 (d, JCP = 11.8 Hz, Ar), 134.7 (d,
JCP = 18.1 Hz, Ar), 134.2 (d, JCP = 2.6 Hz, Ar), 133.2 (d, JCP = 50.9 Hz,
Ar) 132.5 (d, JCP = 37.9 Hz, Ar), 132.0 (s, Ar), 130.9 (d, JCP = 11.2 Hz,
Ar), 130.5 (s, Ar), 130.0 (d, JCP = 13.7 Hz, Ar), 124.1 (s, Ar), 123.4 (d,
JCP = 8.2 Hz, Ar), 48.2 (s, CH3), 44.8 (s, CH3). 31P{1H} NMR (121
31P{1H} NMR (121 MHz, CD3CN) δ: −7.2. IR (CH2Cl2): νCO
̃
=
2150 (m), 2088 (w), 2047 (s) cm−1
.
Anal. Calcd for
C28H26BF4N3O5PRe: C, 42.65; H, 3.32; N, 5.33. Found: C, 42.62;
H, 3.41; N, 5.20.
In Situ Preparation of [ReI(L5-κ1-P)(CO)5](BF4) (5). Because of
its instability with regard to forming the κ2-P,N complex (7) (see
below), complex 5 was not isolated. We identified and characterized it
in solution either from the crude reaction between ReI(CO)5(FBF3)
and 1 equivalent of L5 (ca. 80% yield at early time points) or by
deprotonation of complex 12 (see below) with triethylamine
MHz, CD2Cl2) δ: 14.9. IR (CH3CN): νCO
̃
= 2160 (m), 2054 (s)
cm−1. Anal. Calcd for C31H28B2F8N2O5PRe: C, 41.40; H, 3.14; N, 3.11.
Found: C, 40.89; H, 3.17; N, 2.95.
(quantitative yield). 1H NMR (300 MHz, CD3CN) δ: 7.65−7.80
2
(m, 2H, ArH), 7.35−7.60 (m, 8H, ArH), 4.10 (app. t, JHP = JHH
=
Preparation of [ReI(L2H-κ1-P)(CO)5](BF4)(OTf) (9). Solid 2·THF
(56 mg, 0.065 mmol) was dissolved in 2 mL of CH2Cl2. Via syringe,
HBF4·Et2O (10 μL, 0.075 mmol, 1.1 equiv) was added with stirring,
causing a white solid to precipitate. After stirring briefly, the mixture
was diluted with 4 mL of Et2O and decanted, and the product was
dried in vacuo. Yield: 56 mg (98%). 1H NMR (300 MHz, CD3CN) δ:
8.24 (m, 1H, ArH), 7.95 (m, 2H, ArH), 7.63−7.76 (m, 11H, ArH),
7.48 (br, s, 1H, NH), 3.68 (d, J = 6.3 Hz, 2H, CH2), 2.08 (d, J = 5.1
10.0 Hz, 1H, CH) 3.84 (dd, J = 15.3, 10.4 Hz, 1H, CH2), 2.95−3.32
(m, 5H, CH2), 1.35−2.07 (m, 8H, CH2). 31P{1H} NMR (121 MHz,
CD3CN) δ: 3.6 (br). IR (CH2Cl2) νCO
̃
= 2151 (m), 2091 (w),
2041(s) cm−1.
Preparation of [ReI(L6-κ1-P)(CO)5](BF4) (6). Solid
ReI(CO)5(FBF3) (200 mg, 0.484 mmol) was suspended in 4 mL of
CH2Cl2. A solution of L6 (169 mg, 0.485 mmol, 1.00 equiv) dissolved
in 4 mL of CH2Cl2 was added, producing a colorless solution. After
stirring for 90 min, the solvent was removed in vacuo. The colorless
residue was redissolved in 2 mL of CH2Cl2, and with stirring 6 mL of
Et2O was added. The white solid that precipitated was separated by
decanting the mother liquor and then washed with Et2O and dried in
Hz, 6H, CH3). 13C{1H} NMR (126 MHz, CD3CN) δ: 180.0 (d, 2JCP
8.3 Hz, cis CO), 176.7 (d, JCP = 42.2 Hz, trans CO), 140.7 (d, JCP
21.7 Hz, Ar), 135.8 (d, Jcp = 2.6 Hz, Ar), 134.7 (s, Ar), 133.8 (d, JCP
=
=
=
2
2.0 Hz, Ar), 132.6 (d, JCP = 11.0 Hz, Ar), 132.1 (d, JCP = 6.3 Hz, Ar),
131.8 (d, JCP = 34.8 Hz, Ar), 131.5 (s, Ar), 131.4 (s, Ar), 128.0 (d, JCP
= 49.3 Hz, Ar), 121.9 (quart., 1JCF = 320.1 Hz, CF3), 59.0 (d, JCP = 5.0
Hz, CH2), 43.7 (s, CH3). 31P{1H} NMR (121 MHz, CD3CN) δ: 2.6.
1
vacuo. Yield: 347 mg of 6·CH2Cl2 (84.6%). H NMR (300 MHz,
CD3CN) δ: 7.51−7.65 (m, 6H, ArH), 7.35−7.50 (m, 5H, ArH), 6.82
(d, J = 12.0 Hz, 1H, ArH), 6.58 (s, 1H, OH), 5.45 (s, CH2Cl2), 2.22 (s,
3H, ArCH3), 1.37 (s, 9H, C(CH3)3). 13C{1H} NMR (126 MHz,
CD3CN) δ: 180.8 (d, 2JCP = 6.2 Hz, cis CO), 177.6 (br, d, 2JCP = 42.1
IR (CH3CN): νCO
̃
= 2160 (m), 2053 (s) cm−1. Anal. Calcd for
C27H23BF7NO8PReS: C, 36.75; H, 2.63; N, 1.59. Found: C, 36.76; H,
2.74; N, 1.56.
2
Hz, trans CO), 154.0 (d, JCP = 5.3 Hz, Ar), 139.6 (d, JCP = 5.3 Hz,
Preparation of [ReI(L3H-κ1-P)(CO)5](BF4)2 (10). Complex 3
(100 mg, 0.143 mmol) was dissolved in 2 mL of CH2Cl2. HBF4·Et2O
(20 μL, 0.15 mmol, 1.05 equiv) was added via syringe, which separated
a colorless residue from the solution. After 10 min, the mixture was
diluted with 8 mL of Et2O, and by scraping with a spatula a white solid
was produced. The supernatant was decanted, and the product dried in
Ar), 133.9 (d, JCP = 11.3 Hz, Ar), 133.9 (s, Ar), 133.0 (d, JCP = 2.5 Hz,
Ar), 132.6 (d, JCP = 10.2 Hz, Ar), 131.9 (d, JCP = 5.4 Hz, Ar) 131.4 (d,
JCP = 54.3 Hz, Ar), 130.5 (d, JCP = 11.0 Hz, Ar), 119.0 (d, JCP = 56.1
Hz, Ar), 34.9 (s, C(CH3)3), 30.4 (s, C(CH3)3), 21.0 (s, ArCH3).
31P{1H} NMR (121 MHz, CD2Cl2) δ: −4.6. IR (CH2Cl2): νCO
̃
=
1
2157 (m), 2102 (w), 2048 (s) cm−1
. Anal. Calcd for
vacuo. Yield: 99 mg (88%). H NMR (300 MHz, CD3CN) δ: 7.55−
8.00 (m, 10H, ArH), 7.23 (br, s, 1H, NH), 4.63 (d, J = 5.1 Hz, 2H,
CH2), 3.83 (d, J = 13.5 Hz, 2H, CH2), 3.58 (t, J = 12.0 Hz, 2H, CH2),
3.30 (m, 2H, CH2), 3.09 (d, J = 12.6 Hz, 2H, CH2). 13C{1H} NMR
(126 MHz, CD3CN) δ: 178.7 (d, 2JCP = 6.3 Hz, cis CO), 176.2 (d, 2JCP
= 42.5 Hz, trans CO), 135.0 (s, Ar), 133.5 (d, Jcp = 11.5 Hz, Ar), 131.7
(d, JCP = 11.6 Hz, Ar), 125.2 (d, JCP = 52.5 Hz, Ar), 63.8 (s, CH2), 56.9
(s, CH2), 56.8 (s, CH2, overlap with previous peak). 31P{1H} NMR
C29H27BCl2F4O6PRe (6·CH2Cl2): C, 41.15; H, 3.22; N, 0.00.
Found: C, 40.99; H, 3.16; N, 0.
Preparation of [ReI(L5-κ2-P,N)(CO)4](BF4) (7). A sample of crude
5 (357 mg), prepared by reaction of ReI(CO)5(FBF3) with L5, was
dissolved in 6 mL of CH2Cl2 and held at room temperature for ca. 60
h. The solution was concentrated in vacuo to produce a colorless
residue, which was redissolved in 2 mL of CH2Cl2. Addition of 8 mL
of Et2O separated a white solid; the supernatant was removed and the
(121 MHz, CD3CN) δ: −5.4. IR (CH3CN): νCO
̃
= 2163 (m), 2157
(w), 2056 (s) cm−1. Anal. Calcd for C22H21B2F8NO6PRe: C, 33.61; H,
2.69; N, 1.78. Found: C, 33.70; H, 2.79; N, 1.78.
1
product dried in vacuo. Yield: 325 mg (94.5%). H NMR (300 MHz,
CD2Cl2) δ: 7.45−7.85 (m, 8H, ArH), 7.22−7.32 (m, 2H, ArH), 4.49
(ddd, 2JHP = 14.3 Hz, JHH = 9.8, 2.4 Hz, 1H, CH), 4.24 (dd, JHH = 15.8,
10.4 Hz, 1H, CH2), 3.36−3.76 (m, 5H, CH2), 1.35−2.15 (m, 8H,
CH2). 13C{1H} NMR (126 MHz, CD2Cl2) δ: 186.6 (d, 2JCP = 6.7 Hz,
cis CO), 185.3 (d, 2JCP = 46.9 Hz, trans CO), 185.1 (d, 2JCP = 8.3 Hz,
Preparation of [ReI(L4H-κ1-P)(CO)5](BF4)2 (11). A scintillation
vial was charged with 4 (100 mg, 0.127 mmol) dissolved in 2 mL of
CH2Cl2. To this solution was added HBF4·Et2O (18 μL, 0.13 mmol,
1.05 equiv). A white solid immediately formed, and after 10 min 8 mL
of Et2O was added to the mixture. After allowing the product to settle,
the supernatant was decanted, and the remaining white powder was
washed with Et2O and dried in vacuo. Yield: 110 mg of 11·CH2Cl2
(90.3%). 1H NMR (300 MHz, CD3CN) δ: 8.15 (ddd, J = 17.9, 7.8, 1.6
Hz, 1H, ArH), 7.64−7.89 (m, 12H, ArH), 6.94 (dd, J = 8.1, 4.1 Hz,
1H, ArH), 5.73 (s, 1H, NH), 5.45 (s, CH2Cl2), 2.40 (br, s, 12H, CH3).
2
2
cis CO), 183.6 (d, JCP = 8.4 Hz, cis CO), 171.2 (d, JCP = 12.3 Hz,
CN), 135.3 (d, JCP = 12.7 Hz, Ar), 134.8 (s, Ar), 133.9 (d, JCP = 2.6
Hz, Ar), 132.1 (d, JCP = 2.4 Hz, Ar), 130.6 (d, JCP = 11.6 Hz, Ar),
130.2 (d, JCP = 10.4 Hz, Ar) 130.0 (d, JCP = 10.1 Hz, Ar), 125.6 (d, JCP
= 56.1 Hz, Ar), 58.1 (d, JCP = 4.7 Hz, CH2), 56.1 (s, CH2), 49.2 (d, JCP
= 34.6 Hz, CH), 49.1 (s, CH2), 28.0 (d, JCP = 9.4 Hz, CH2), 27.1 (s,
CH2), 26.8 (s, CH2), 23.1 (s, CH2). 31P{1H} NMR (121 MHz,
2
13C{1H} NMR (126 MHz, CD3CN) δ: 179.8 (d, JCP = 8.3 Hz, cis
CD2Cl2) δ: 23.4. IR (CH2Cl2): νCO
̃
= 2109 (m), 2020 (s), 2006 (s),
CO), 176.6 (d, 2JCP = 42.5 Hz, trans CO), 157.4 (s, CN), 140.3 (d,
Jcp = 20.4 Hz, Ar), 140.0 (d, JCP = 2.3 Hz, Ar), 137.1 (d, JCP = 2.4 Hz,
Ar), 134.1 (d, JCP = 2.6 Hz, Ar), 132.6 (d, JCP = 11.2 Hz, Ar), 131.6 (d,
JCP = 10.9 Hz, Ar), 129.2 (d, JCP = 50.6 Hz, Ar), 127.7 (d, JCP = 14.0
Hz, Ar), 123.9 (s, Ar), 117.8 (d, JCP = 48.6 Hz, Ar), 55.3 (s, CH2Cl2),
1968 (s) cm−1. Anal. Calcd for C25H25BF4N2O4PRe: C, 41.62; H, 3.49;
N, 3.88. Found: C, 40.97; H, 3.56; N, 3.66.
Preparation of [ReI(L1H-κ1-P)(CO)5](BF4)2 (8). A scintillation vial
was charged with 1 (100 mg, 0.123 mmol) dissolved in 4 mL of
5541
dx.doi.org/10.1021/om400810v | Organometallics 2013, 32, 5530−5545